The global oligonucleotide synthesis market is projected to grow at a CAGR of 10%-12% during 2020-2026. The growth of oligonucleotide synthesis market is driven by rising research activities in synthetic biology, increasing prevalence of cancer & infectious diseases, and growing demand for innovative and therapeutic techniques.
Some of the Key Questions answered in this exclusive report are:
Q.1 What are some of the
most promising, high-growth opportunities for the oligonucleotide synthesis market
by offering (synthesized oligonucleotides (products (oligonucleotide-based
drugs, primers, probes, large-scale synthesis oligonucleotides, intermediate-scale
synthesis oligonucleotides, and linkers & adaptors), services (custom
oligonucleotides and pre-designed oligonucleotides), reagents &
consumables, and equipment), application (research (PCR, qPCR, sequencing, gene
synthesis, and other research applications), diagnostics, therapeutics (DNA
& antisense oligonucleotide-based therapies, RNAi oligonucleotide-based
therapies, and CPG oligonucleotide-based therapies)), end user (academic &
research institutes, pharmaceutical & biotechnology companies, diagnostic
laboratories, and hospitals), and region (North America, Europe, Asia Pacific,
and Rest of the World)?
Q.2 Which segments will
grow at a faster pace and why?
Q.3 What are the
business risks and threats to the oligonucleotide synthesis market?
Q.4 What are some
changing demands of customers in the oligonucleotide synthesis market?
Q.5 What are the new
developments in the oligonucleotide synthesis market? Which companies are
leading these developments?
Q.6 What strategic
initiatives are being implemented by key players for business growth?
Q.7 What are some of the
competitive products and processes in this oligonucleotide synthesis area and
how big of a threat do they pose for loss of market share via product
substitution?
Q.8 What M&A
activity has occurred in the last 5 years in this oligonucleotide synthesis market?
Download Brochure of this report by clicking on https://www.lucintel.com/oligonucleotide-synthesis-market.aspx
Market Segmentation:
Based on offering, the oligonucleotide
synthesis market is segmented into synthesized oligonucleotides (products
(oligonucleotide-based drugs, primers, probes, large-scale synthesis
oligonucleotides, intermediate-scale synthesis oligonucleotides, and linkers
& adaptors), services (custom oligonucleotides and pre-designed
oligonucleotides), reagents & consumables, and equipment). The synthesized
oligonucleotides segment accounted for the largest share of the market in 2020 due
to rising research and development activities related to oligonucleotide-based
drugs.
North America is
expected to be the largest region over the forecast period due to rising
research and development activities related to life science and the increasing
number of oligonucleotide-based drugs/therapies being approved by the FDA (Food
and Drug Administration) in the region.
Key Players in the oligonucleotide
synthesis market are General Electric, Merck, Eurofins Scientific, Agilent
Technologies, LGC Biosearch Technologies, Integrated DNA Technologies,
GeneDesign, Nitto Denko Avecia, Trilink Biotechnologies, and Kaneka Eurogentec.
Request Sample Pages by clicking on
https://www.lucintel.com/oligonucleotide-synthesis-market.aspx
The
report helps stakeholders understand the pulse of the market and provides them
with information on key drivers, restraints, challenges, and opportunities for
market growth. It would also help to understand the competitors better and gain
more insights to improve their position in the business.
To read more about this market please click on
https://www.lucintel.com/oligonucleotide-synthesis-market.aspx
About
Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Brandon
Fitzgerald
Lucintel
Dallas,
Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Surgical
Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx
Metabolomics
Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx
Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx
Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx
Tumor Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx
Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx
Urology
Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx
Halal Ingredient Market:
For more details click here https://www.lucintel.com/halal-ingredient-market.aspx
Gene
Expression Market:
For more details click here https://www.lucintel.com/gene-expression-market.aspx
GMO Testing Market:
For more details click here https://www.lucintel.com/gmo-testing-market.aspx
No comments:
Post a Comment